Monthly Archives: March 2013

Weekly Roundup – 3-29-13

Posted on March 29, 2013 by Mark Senak

Spring has started, but not sprung.  Not really.  In the days since Spring first started a mere 9 days ago, we have had more snow in the Washington, D.C. area than we had all winter.  Still, the daffodils have shown … Continue reading →

Posted in Weekly Roundup | Comments Off on Weekly Roundup – 3-29-13

Upcoming FDA Advisory Committee Meetings and Topics

Posted on March 28, 2013 by Mark Senak

In January Eye on FDA ran a look at the upcoming advisory committee meetings and their topics and it is time for an update. It turns out that April is a ridiculously busy AdComm month, but there are some interesting … Continue reading →

Posted in Advisory Committee Prepapartion | Comments Off on Upcoming FDA Advisory Committee Meetings and Topics

Weekly Roundup! Back again! – 3/22/13

Posted on March 22, 2013 by Mark Senak

I miss doing the Weekly Roundup and so I am bringing it back.  Part of the reason that it subsided is that I have been working hard on a rather large project that is now concluded, so let’s round up … Continue reading →

Posted in Weekly Roundup | 1 Comment

Tracking Legislation

Posted on March 18, 2013 by Mark Senak

Last week I posted some of the latest legislative proposals out of the 113th Congress that would affect either some aspect of the pharma industry or FDA.  That information is housed on a tab on the Eye on FDA site … Continue reading →

Posted in Proposed Legislation, Useful Resources | Comments Off on Tracking Legislation

Proposed Legislation in the 113th Congress

Posted on March 13, 2013 by Mark Senak

During the course of the 112th Congress, there was a good deal of legislation introduced that, if passed, would impact either the pharmaceutical industry or FDA itself.  Much of that legislation did not pass but some of it has found … Continue reading →

Posted in Proposed Legislation | Comments Off on Proposed Legislation in the 113th Congress